Macaione & Papa

 ESKATA® is the first and only FDA-approved topical treatment for raised SKs (Seborrheic Keratoses).  ESKATA is a prescription medicine used to treat seborrheic keratosis that are raised. ESKATA is for use as an in-office treatment, which is applied by your healthcare provider and is not for use at home.

5 Key SK Questions

  1. What are these spots on my face?  If they are SKs they are harmless, non-cancerous growths.  The spots can be flat or raised with a color that is normal skin tone or darker. SKs can have a velvety, shiny, or wart-like texture and grow thicker. Over time, they may get bigger and more may show up.
  2. Why did I get them?  Some risk factors include age and genetics.
  3. How are they treated with ESKATA?  ESKATA provides: The only FDA-approved, topical treatment that can treat raised SKs.  A proprietary solution based on a high concentration of hydrogen peroxide that your healthcare provider applies directly to raised SKs using a soft-tip, pen-like applicator.  Topical treatment of raised SKs with a low risk of scarring (3% of patients in clinical studies).
  4. What is ESKATA treatment like? ESKATA is applied with a soft-tip, pen-like applicator at your healthcare provider’s office. Your healthcare provider will treat each raised SK 4 times, approximately 1 minute apart. The most common side effects of ESKATA include itching, stinging, crusting, swelling, redness, and scaling. ESKATA is not covered by insurance; it is a self-pay treatment. ESKATA should not be used on open or infected lesions.
  5. When will I see results?  Your healthcare provider will evaluate your results approximately 3 weeks after treatment with ESKATA. If your treated raised SKs are not clear, your healthcare provider may apply ESKATA once more, as long as the treatment area is not irritated. In clinical studies, results were evaluated at Day 106 after initial treatment.